For citations:
Eliseev MS, Zhelyabina OV, Markelova EI, Novikova DS, Vladimirov SA, Korsakova YO, Aleksandrova EN, Novikov AA, Nasonov EL. Assessment of cardiovascular risk from the use of an interleukin-1 inhibitor in patients with severe tophaceous gout. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2016;10(1):7-14. (In Russ.) https://doi.org/10.14412/1996-7012-2016-1-7-14